Investigational Drug Information for Mirogabalin
✉ Email this page to a colleague
What is the development status for investigational drug Mirogabalin?
Mirogabalin is an investigational drug.
There have been 9 clinical trials for Mirogabalin.
The most recent clinical trial was a Phase 3 trial, which was initiated on October 27th 2014.
The most common disease conditions in clinical trials are Neuralgia, Myofascial Pain Syndromes, and Fibromyalgia. The leading clinical trial sponsors are Daiichi Sankyo Co., Ltd., INC Research, and Syneos Health.
Summary for Mirogabalin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 32 |
| WIPO Patent Applications | 19 |
| Japanese Patent Applications | 8 |
| Clinical Trial Progress | Phase 3 (2014-10-27) |
| Vendors | 45 |
Recent Clinical Trials for Mirogabalin
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain | Daiichi Sankyo Co., Ltd. | Phase 3 |
| Study of Mirogabalin for Central Neuropathic Pain | Daiichi Sankyo Co., Ltd. | Phase 3 |
| DS-5565 Phase III Study for Renal Impairment in Japanese Subjects | CMIC Co, Ltd. Japan | Phase 3 |
Clinical Trial Summary for Mirogabalin
Top disease conditions for Mirogabalin
Top clinical trial sponsors for Mirogabalin
US Patents for Mirogabalin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
